We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Neutra Corporation (CE) | USOTC:NTRR | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 60,945 | 00:00:00 |
The preliminary results of lab testing on the suite of horticultural products being marketed by Neutra Corp. (OTCBB: NTRR) and its joint venture partner, Surface to Air Solutions, Inc. (S2O2), have so far exceeded all expectations, the company announced today.
For weeks, the product suite’s efficacy in eliminating potentially harmful contaminants from plants, surfaces and air inside cannabis growing facilities in Colorado has been tested by an independent laboratory in order to prove the joint venture’s claims. The third-party lab has collected weekly surface samples at the cultivation operations where the joint venture’s products are being tested.
“The UV light used in the Colorado growing operation creates the perfect environment for our antimicrobial surface coatings and air-scrubbing hydroxyl generator to be effective,” Brown said. “We’re already receiving interest from local growers, and testing hasn’t even been completed yet.”
The antimicrobial surface treatment, nutritional plant tonic and air-scrubbing hydroxyl generator being marketed by the joint venture is scheduled to be tested at facilities run by Colorado’s DANK Dispensaries and Denver Consulting Group for three months. NTRR formed its joint venture with S2O2 last year to market these and other novel solutions to growers that are concerned about contamination of their crops by microbes, molds, fungus and other pests.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Neutra Corp.Chris Brown, 813-367-2041President and CEOinfo@neutracorp.com
1 Year Neutra (CE) Chart |
1 Month Neutra (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions